{
  "id": "6415c9e9690f196b51000018",
  "type": "factoid",
  "question": "Which form of breast cancer has Keytruda been FDA approved for?",
  "ideal_answer": "Keytruda has been FDA approved for use in combination with chemotherapy for treating PD-L1-positive mTNBC.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/33983696"
  ],
  "snippets": [
    {
      "text": "The combination of chemotherapy and immunotherapy is a potential therapeutic option for PD-L1-positive mTNBC, as the FDA recently approved atezolizumab (Tecentriq) and pembrolizumab (Keytruda) in combination with chemotherapy. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33983696",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "triple-negative breast cancer"
}